GAP launches mobile health site for clinical trials
Individuals who are usually at risk of developing Alzheimer’s can take part in pre-screening visits at every mobile site stop.
Central Nervous System
Latest in
Central Nervous System
Clene’s CNM-Au8 boosts survival in amyotrophic lateral sclerosis trial
CNM-Au8 was found to be well-tolerated without any significant safety findings observed in the trial.
Clinilabs begins enrolment in Phase I/IIa major depressive disorder trial
The trial will evaluate onset of antidepressant effect offered by CYB003 using Montgomery-Asberg Depression Rating Scale.
Lipocine to commence Phase II epilepsy treatment trial
The trial will evaluate the safety, tolerability, and efficacy of oral LPCN 2101.
Cybin completes purchase of anxiety disorder treatment study
The acquisition is expected to accelerate clinical development pathway of CYB004 by nine months.
Pipeline Moves: Novartis suspends platform trial, advancement shot of four blood cancer assets drop
We also review primary systemic amyloidosis, tuberculosis, and uterine leiomyoma trial terminations.
By
SciSparc to seek FDA approval for Phase IIb Tourette Syndrome trial
The Phase IIb trial will assess SCI-110’s tolerability, safety, and efficacy in adult Tourette Syndrome patients.
Biohaven enrols first subject in Phase III spinal muscle atrophy trial
The trial will analyse the safety and efficacy of taldefgrobep as an adjunctive treatment for SMA.